Observing antibiotic use in children with pneumonia
Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia: a Prospective, Observational Study
This study looks at how often children with pneumonia in the hospital are given antibiotics and how parents feel about their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 3 Months to 18 Years |
| Sex | All |
| Sponsor | ARCIM Institute Academic Research in Complementary and Integrative Medicine Academic / other |
| Locations | 2 sites (Filderstadt, Baden-Wurttemberg and 1 other locations) |
| Trial ID | NCT04681339 on ClinicalTrials.gov |
What this trial studies
This observational study aims to document the rate of antibiotic prescriptions in children hospitalized for community-acquired pneumonia at a pediatric department known for its restrictive antibiotic prescribing practices. It will assess how physicians make decisions regarding antibiotic use and will also evaluate parental satisfaction with the treatment process. Data will be collected on the severity of the disease, medical complications, and the frequency of factors influencing antibiotic decisions. Parents will be contacted four weeks post-discharge to gather information on any recurrence or readmission.
Who should consider this trial
Good fit: Ideal candidates include children hospitalized for pneumonia at the participating pediatric departments.
Not a fit: Patients who do not have pneumonia or those who are not admitted to the specified hospitals may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve antibiotic stewardship practices and enhance treatment outcomes for children with pneumonia.
How similar studies have performed: Other studies have shown success in improving antibiotic prescribing practices through observational approaches, indicating that this methodology is both relevant and tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hospital admission at the pediatric department of the Filderklinik or at the pediatric department of the Herdecke Community Hospital * Admission diagnosis pneumonia or pneumonia diagnosis within 48 hours of admission * Written informed consent by care giver * All inclusion criteria have to be fulfilled Exclusion Criteria: * Insufficient knowledge of German to understand the written patient information and questionnaire
Where this trial is running
Filderstadt, Baden-Wurttemberg and 1 other locations
- Die Filderklinik — Filderstadt, Baden-Wurttemberg, Germany (Recruiting)
- Herdecke Community Hospital — Herdecke, North Rhine-Westphalia, Germany (Recruiting)
Study contacts
- Principal investigator: Jan Vagedes, Dr — Arcim Institute
- Study coordinator: Jan Vagedes, Dr
- Email: j.vagedes@arcim-institute.de
- Phone: +49 711 7703
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.